0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Flu Vaccine Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2021-2027
Published Date: September 2021
|
Report Code: QYRE-Auto-11H675
Home | Market Reports | Health | Health Conditions | Infectious Diseases
Global Flu Vaccine Market Size Manufacturers Supply Chain Sales Channel and Clients 2021 2027

Global Flu Vaccine Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2021-2027

Code: QYRE-Auto-11H675
Report
September 2021
115 Pages
QYResearch
Region: Global, North America, China, Europe, France, Germany, Italy, Japan, South Korea, Philippines, Malaysia, Taiwan, Indonesia, Saudi Arabia, Turkey, India, Australia, Thailand,
Description
Table of Content
Tables & Figures
Influenza vaccines, also known as flu shots, are vaccines that protect against influenza. A new version of the vaccine is developed twice a year as the influenza virus rapidly changes. Most provide modest to high protection against influenza; however, each year this varies. Evidence in adults over 65 years old is poor. They decrease the number of missed days of work by a half day on average. Vaccinating children may protect those around them.

Global Flu Vaccine key players include Sanofi Pasteur, CSL, GSK, etc. Global top three manufacturers hold a share over 75%.

North America is the largest market, with a share about 40%, followed by Europe, and Asia-Pacific, both have a share about 45 percent.
In terms of product, Quadrivalent Influenza Vaccine is the largest segment, with a share nearly 85%. And in terms of application, the largest application is For Adults and Children over 3 years, followed by For Children (6 months to 3 years).
Market Analysis and Insights: Global Flu Vaccine Market

In 2020, the global Flu Vaccine market size was US$ 5154 million and it is expected to reach US$ 7293.3 million by the end of 2027, with a CAGR of 4.8% during 2021-2027.

Global Flu Vaccine Scope and Market Size
Flu Vaccine market is segmented by region, by country, company, type, application and by sales channels. Players, stakeholders, and other participants in the global Flu Vaccine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region, by country, company, type, application and by sales channels for the period 2016-2027.

Segment by Type, the Flu Vaccine market is segmented into

Trivalent Influenza Vaccine
Quadrivalent Influenza Vaccine

Segment by Application, the Flu Vaccine market is segmented into

For Children (6 months to 3 years)
For Adults and Children over 3 years
Regional and Country-level Analysis:
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Competitive Landscape and Flu Vaccine Market Share Analysis
Flu Vaccine market competitive landscape provides details and data information by companies. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2016-2021. It also offers detailed analysis supported by reliable statistics on sale and revenue by players for the period 2016-2021. Details included are company description, major business, Flu Vaccine product introduction, recent developments, Flu Vaccine sales by region, type, application and by sales channel.
The major companies include:
Sanofi Pasteur
CSL
GSK
Mylan
Hulan Bio
AstraZeneca
CCBIO
1 Study Coverage
1.1 Flu Vaccine Product Introduction
1.2 Market by Type
1.2.1 Global Flu Vaccine Market Size Growth Rate by Type
1.2.2 Trivalent Influenza Vaccine
1.2.3 Quadrivalent Influenza Vaccine
1.3 Market by Application
1.3.1 Global Flu Vaccine Market Size Growth Rate by Application
1.3.2 For Children (6 months to 3 years)
1.3.3 For Adults and Children over 3 years
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Flu Vaccine Market Size Estimates and Forecasts
2.1.1 Global Flu Vaccine Revenue 2016-2027
2.1.2 Global Flu Vaccine Sales 2016-2027
2.2 Flu Vaccine Market Size by Region: 2021 Versus 2027
2.3 Flu Vaccine Sales by Region (2016-2027)
2.3.1 Global Flu Vaccine Sales by Region: 2016-2021
2.3.2 Global Flu Vaccine Sales Forecast by Region (2022-2027)
2.3.3 Global Flu Vaccine Sales Market Share by Region (2016-2027)
2.4 Flu Vaccine Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Flu Vaccine Revenue by Region: 2016-2021
2.4.2 Global Flu Vaccine Revenue Forecast by Region (2022-2027)
2.4.3 Global Flu Vaccine Revenue Market Share by Region (2016-2027)
3 Global Flu Vaccine by Manufacturers
3.1 Global Top Flu Vaccine Manufacturers by Sales
3.1.1 Global Flu Vaccine Sales by Manufacturer (2016-2021)
3.1.2 Global Flu Vaccine Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Flu Vaccine Manufacturers by Revenue
3.2.1 Global Flu Vaccine Revenue by Manufacturer (2016-2021)
3.2.2 Global Flu Vaccine Revenue Share by Manufacturer (2016-2021)
3.3 Global Flu Vaccine Price by Manufacturer (2016-2021)
3.4 Competitive Landscape
3.4.1 Key Flu Vaccine Manufacturers Covered: Ranking by Revenue
3.4.2 Global Flu Vaccine Market Concentration Ratio (CR5 and HHI) & (2016-2021)
3.4.3 Global Flu Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.5 Global Flu Vaccine Manufacturing Base Distribution, Product Type
3.5.1 Flu Vaccine Manufacturers Manufacturing Base Distribution, Headquarters
3.5.2 Manufacturers Flu Vaccine Product Type
3.5.3 Date of International Manufacturers Enter into Flu Vaccine Market
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Company Profiles
4.1 Sanofi Pasteur
4.1.1 Sanofi Pasteur Corporation Information
4.1.2 Sanofi Pasteur Description, Business Overview
4.1.3 Sanofi Pasteur Flu Vaccine Products Offered
4.1.4 Sanofi Pasteur Flu Vaccine Sales, Revenue and Gross Margin (2016-2021)
4.1.5 Sanofi Pasteur Flu Vaccine Revenue by Product
4.1.6 Sanofi Pasteur Flu Vaccine Revenue by Application
4.1.7 Sanofi Pasteur Flu Vaccine Revenue by Geographic Area
4.1.8 Sanofi Pasteur Flu Vaccine Revenue by Sales Channel
4.1.9 Sanofi Pasteur Recent Development
4.2 CSL
4.2.1 CSL Corporation Information
4.2.2 CSL Description, Business Overview
4.2.3 CSL Flu Vaccine Products Offered
4.2.4 CSL Flu Vaccine Sales, Revenue and Gross Margin (2016-2021)
4.2.5 CSL Flu Vaccine Revenue by Product
4.2.6 CSL Flu Vaccine Revenue by Application
4.2.7 CSL Flu Vaccine Revenue by Geographic Area
4.2.8 CSL Flu Vaccine Revenue by Sales Channel
4.2.9 CSL Recent Development
4.3 GSK
4.3.1 GSK Corporation Information
4.3.2 GSK Description, Business Overview
4.3.3 GSK Flu Vaccine Products Offered
4.3.4 GSK Flu Vaccine Sales, Revenue and Gross Margin (2016-2021)
4.3.5 GSK Flu Vaccine Revenue by Product
4.3.6 GSK Flu Vaccine Revenue by Application
4.3.7 GSK Flu Vaccine Revenue by Geographic Area
4.3.8 GSK Flu Vaccine Revenue by Sales Channel
4.3.9 GSK Recent Development
4.4 Mylan
4.4.1 Mylan Corporation Information
4.4.2 Mylan Description, Business Overview
4.4.3 Mylan Flu Vaccine Products Offered
4.4.4 Mylan Flu Vaccine Sales, Revenue and Gross Margin (2016-2021)
4.4.5 Mylan Flu Vaccine Revenue by Product
4.4.6 Mylan Flu Vaccine Revenue by Application
4.4.7 Mylan Flu Vaccine Revenue by Geographic Area
4.4.8 Mylan Flu Vaccine Revenue by Sales Channel
4.4.9 Mylan Recent Development
4.5 Hulan Bio
4.5.1 Hulan Bio Corporation Information
4.5.2 Hulan Bio Description, Business Overview
4.5.3 Hulan Bio Flu Vaccine Products Offered
4.5.4 Hulan Bio Flu Vaccine Sales, Revenue and Gross Margin (2016-2021)
4.5.5 Hulan Bio Flu Vaccine Revenue by Product
4.5.6 Hulan Bio Flu Vaccine Revenue by Application
4.5.7 Hulan Bio Flu Vaccine Revenue by Geographic Area
4.5.8 Hulan Bio Flu Vaccine Revenue by Sales Channel
4.5.9 Hulan Bio Recent Development
4.6 AstraZeneca
4.6.1 AstraZeneca Corporation Information
4.6.2 AstraZeneca Description, Business Overview
4.6.3 AstraZeneca Flu Vaccine Products Offered
4.6.4 AstraZeneca Flu Vaccine Sales, Revenue and Gross Margin (2016-2021)
4.6.5 AstraZeneca Flu Vaccine Revenue by Product
4.6.6 AstraZeneca Flu Vaccine Revenue by Application
4.6.7 AstraZeneca Flu Vaccine Revenue by Geographic Area
4.6.8 AstraZeneca Recent Development
4.7 CCBIO
4.7.1 CCBIO Corporation Information
4.7.2 CCBIO Description, Business Overview
4.7.3 CCBIO Flu Vaccine Products Offered
4.7.4 CCBIO Flu Vaccine Sales, Revenue and Gross Margin (2016-2021)
4.7.5 CCBIO Flu Vaccine Revenue by Product
4.7.6 CCBIO Flu Vaccine Revenue by Application
4.7.7 CCBIO Flu Vaccine Revenue by Geographic Area
4.7.8 CCBIO Recent Development
5 Breakdown Data by Type
5.1 Global Flu Vaccine Sales by Type (2016-2027)
5.1.1 Global Flu Vaccine Sales by Type (2016-2021)
5.1.2 Global Flu Vaccine Sales Forecast by Type (2022-2027)
5.1.3 Global Flu Vaccine Sales Market Share by Type (2016-2027)
5.2 Global Flu Vaccine Revenue Forecast by Type (2016-2027)
5.2.1 Global Flu Vaccine Revenue by Type (2016-2021)
5.2.2 Global Flu Vaccine Revenue Forecast by Type (2022-2027)
5.2.3 Global Flu Vaccine Revenue Market Share by Type (2016-2027)
5.3 Flu Vaccine Average Selling Price (ASP) by Type (2016-2027)
6 Breakdown Data by Application
6.1 Global Flu Vaccine Sales by Application (2016-2027)
6.1.1 Global Flu Vaccine Sales by Application (2016-2021)
6.1.2 Global Flu Vaccine Sales Forecast by Application (2022-2027)
6.1.3 Global Flu Vaccine Sales Market Share by Application (2016-2027)
6.2 Global Flu Vaccine Revenue Forecast by Application (2016-2027)
6.2.1 Global Flu Vaccine Revenue by Application (2016-2021)
6.2.2 Global Flu Vaccine Revenue Forecast by Application (2022-2027)
6.2.3 Global Flu Vaccine Revenue Market Share by Application (2016-2027)
6.3 Flu Vaccine Average Selling Price (ASP) by Application (2016-2027)
7 North America
7.1 North America Flu Vaccine Market Size YoY Growth 2016-2027
7.2 North America Flu Vaccine Market Facts & Figures by Country
7.2.1 North America Flu Vaccine Sales by Country (2016-2027)
7.2.2 North America Flu Vaccine Revenue by Country (2016-2027)
7.3 North America Flu Vaccine Sales by Type
7.4 North America Flu Vaccine Sales by Application
8 Asia-Pacific
8.1 Asia-Pacific Flu Vaccine Market Size YoY Growth 2016-2027
8.2 Asia-Pacific Flu Vaccine Market Facts & Figures by Region
8.2.1 Asia-Pacific Flu Vaccine Sales by Region (2016-2027)
8.2.2 Asia-Pacific Flu Vaccine Revenue by Region (2016-2027)
8.3 Asia-Pacific Flu Vaccine Sales by Type
8.4 Asia-Pacific Flu Vaccine Sales by Application
9 Europe
9.1 Europe Flu Vaccine Market Size YoY Growth 2016-2027
9.2 Europe Flu Vaccine Market Facts & Figures by Country
9.2.1 Europe Flu Vaccine Sales by Country (2016-2027)
9.2.2 Europe Flu Vaccine Revenue by Country (2016-2027)
9.3 Europe Flu Vaccine Sales by Type
9.4 Europe Flu Vaccine Sales by Application
10 Latin America
10.1 Latin America Flu Vaccine Market Size YoY Growth 2016-2027
10.2 Latin America Flu Vaccine Market Facts & Figures by Country
10.2.1 Latin America Flu Vaccine Sales by Country (2016-2027)
10.2.2 Latin America Flu Vaccine Revenue by Country (2016-2027)
10.3 Latin America Flu Vaccine Sales by Type
10.4 Latin America Flu Vaccine Sales by Application
11 Middle East and Africa
11.1 Middle East and Africa Flu Vaccine Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Flu Vaccine Market Facts & Figures by Country
11.2.1 Middle East and Africa Flu Vaccine Sales by Country (2016-2027)
11.2.2 Middle East and Africa Flu Vaccine Revenue by Country (2016-2027)
11.3 Middle East and Africa Flu Vaccine Sales by Type
11.4 Middle East and Africa Flu Vaccine Sales by Application
12 Supply Chain and Sales Channel Analysis
12.1 Flu Vaccine Supply Chain Analysis
12.2 Flu Vaccine Key Raw Materials and Upstream Suppliers
12.3 Flu Vaccine Clients Analysis
12.4 Flu Vaccine Sales Channel and Sales Model Analysis
12.4.1 Flu Vaccine Distribution Channel Analysis: Indirect Sales VS Direct Sales
12.4.2 Flu Vaccine Distribution Channel Analysis: Online Sales VS Offline Sales
12.4.3 Flu Vaccine Distributors
13 Market Dynamics
13.1 Flu Vaccine Market Drivers
13.2 Flu Vaccine Market Opportunities
13.3 Flu Vaccine Market Challenges
13.4 Flu Vaccine Market Restraints
13.5 Porter’s Five Forces Analysis
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
    Table 1. Global Flu Vaccine Market Size Growth Rate by Type (US$ Million): 2021 VS 2027
    Table 2. Major Manufacturers of Trivalent Influenza Vaccine
    Table 3. Major Manufacturers of Quadrivalent Influenza Vaccine
    Table 4. Global Flu Vaccine Market Size Growth by Application (US$ Million): 2021 VS 2027
    Table 5. Global Flu Vaccine Market Size by Region (US$ Million): 2021 VS 2027
    Table 6. Global Flu Vaccine Sales by Region (2016-2021) & (M Doses)
    Table 7. Global Flu Vaccine Sales Forecast by Region (2022-2027) & (M Doses)
    Table 8. Global Flu Vaccine Revenue by Region (2016-2021) & (US$ Million)
    Table 9. Global Flu Vaccine Revenue Forecast by Region (2022-2027) & (US$ Million)
    Table 10. Global Flu Vaccine Sales by Manufacturer (2016-2021) & (M Doses)
    Table 11. Global Flu Vaccine Sales Share by Manufacturer (2016-2021)
    Table 12. Flu Vaccine Revenue by Manufacturer (2016-2021) & (US$ Million)
    Table 13. Flu Vaccine Revenue Share by Manufacturer (2016-2021)
    Table 14. Key Manufacturers Flu Vaccine Price (2016-2021) & (US$/Dose)
    Table 15. Ranking of Global Top Flu Vaccine Manufacturers by Revenue (US$ Million) in 2020
    Table 16. Global Flu Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
    Table 17. Global Flu Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Flu Vaccine as of 2020)
    Table 18. Flu Vaccine Manufacturers Manufacturing Base Distribution and Headquarters
    Table 19. Manufacturers Flu Vaccine Product Type
    Table 20. Date of International Manufacturers Enter into Flu Vaccine Market
    Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 22. Sanofi Pasteur Corporation Information
    Table 23. Sanofi Pasteur Description and Business Overview
    Table 24. Sanofi Pasteur Flu Vaccine Sales (M Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2016-2021)
    Table 25. Sanofi Pasteur Flu Vaccine Product
    Table 26. Sanofi Pasteur Flu Vaccine Revenue (US$ Million) and Market Share by Product
    Table 27. Sanofi Pasteur Flu Vaccine Revenue (US$ Million) and Market Share by Application
    Table 28. Sanofi Pasteur Flu Vaccine Revenue (US$ Million) and Market Share by Geographic Area
    Table 29. Sanofi Pasteur Flu Vaccine Revenue (US$ Million) and Market Share by Sales Channel
    Table 30. Sanofi Pasteur Recent Development
    Table 31. CSL Corporation Information
    Table 32. CSL Description and Business Overview
    Table 33. CSL Flu Vaccine Sales (M Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2016-2021)
    Table 34. CSL Flu Vaccine Product
    Table 35. CSL Flu Vaccine Revenue (US$ Million) and Market Share by Product
    Table 36. CSL Flu Vaccine Revenue (US$ Million) and Market Share by Application
    Table 37. CSL Flu Vaccine Revenue (US$ Million) and Market Share by Geographic Area
    Table 38. CSL Flu Vaccine Revenue (US$ Million) and Market Share by Sales Channel
    Table 39. CSL Recent Development
    Table 40. GSK Corporation Information
    Table 41. GSK Description and Business Overview
    Table 42. GSK Flu Vaccine Sales (M Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2016-2021)
    Table 43. GSK Flu Vaccine Product
    Table 44. GSK Flu Vaccine Revenue (US$ Million) and Market Share by Product
    Table 45. GSK Flu Vaccine Revenue (US$ Million) and Market Share by Application
    Table 46. GSK Flu Vaccine Revenue (US$ Million) and Market Share by Geographic Area
    Table 47. GSK Flu Vaccine Revenue (US$ Million) and Market Share by Sales Channel
    Table 48. GSK Recent Development
    Table 49. Mylan Corporation Information
    Table 50. Mylan Description and Business Overview
    Table 51. Mylan Flu Vaccine Sales (M Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2016-2021)
    Table 52. Mylan Flu Vaccine Product
    Table 53. Mylan Flu Vaccine Revenue (US$ Million) and Market Share by Product
    Table 54. Mylan Flu Vaccine Revenue (US$ Million) and Market Share by Application
    Table 55. Mylan Flu Vaccine Revenue (US$ Million) and Market Share by Geographic Area
    Table 56. Mylan Flu Vaccine Revenue (US$ Million) and Market Share by Sales Channel
    Table 57. Mylan Recent Development
    Table 58. Hulan Bio Corporation Information
    Table 59. Hulan Bio Description and Business Overview
    Table 60. Hulan Bio Flu Vaccine Sales (M Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2016-2021)
    Table 61. Hulan Bio Flu Vaccine Product
    Table 62. Hulan Bio Flu Vaccine Revenue (US$ Million) and Market Share by Product
    Table 63. Hulan Bio Flu Vaccine Revenue (US$ Million) and Market Share by Application
    Table 64. Hulan Bio Flu Vaccine Revenue (US$ Million) and Market Share by Geographic Area
    Table 65. Hulan Bio Flu Vaccine Revenue (US$ Million) and Market Share by Sales Channel
    Table 66. Hulan Bio Recent Development
    Table 67. AstraZeneca Corporation Information
    Table 68. AstraZeneca Description and Business Overview
    Table 69. AstraZeneca Flu Vaccine Sales (M Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2016-2021)
    Table 70. AstraZeneca Flu Vaccine Product
    Table 71. AstraZeneca Flu Vaccine Revenue (US$ Million) and Market Share by Product
    Table 72. AstraZeneca Flu Vaccine Revenue (US$ Million) and Market Share by Application
    Table 73. AstraZeneca Flu Vaccine Revenue (US$ Million) and Market Share by Geographic Area
    Table 74. AstraZeneca Recent Development
    Table 75. CCBIO Corporation Information
    Table 76. CCBIO Description and Business Overview
    Table 77. CCBIO Flu Vaccine Sales (M Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2016-2021)
    Table 78. CCBIO Flu Vaccine Product
    Table 79. CCBIO Flu Vaccine Revenue (US$ Million) and Market Share by Product
    Table 80. CCBIO Flu Vaccine Revenue (US$ Million) and Market Share by Application
    Table 81. CCBIO Flu Vaccine Revenue (US$ Million) and Market Share by Geographic Area
    Table 82. CCBIO Recent Development
    Table 83. Global Flu Vaccine Sales by Type (2016-2021) & (M Doses)
    Table 84. Global Flu Vaccine Sales Forecast by Type (2022-2027) & (M Doses)
    Table 85. Global Flu Vaccine Revenue by Type (2016-2021) & (US$ Million)
    Table 86. Global Flu Vaccine Revenue Forecast by Type (2022-2027) & (US$ Million)
    Table 87. Global Flu Vaccine Sales by Application (2016-2021) & (M Doses)
    Table 88. Global Flu Vaccine Sales Forecast by Application (2022-2027) & (M Doses)
    Table 89. Global Flu Vaccine Revenue by Application (2016-2021) & (US$ Million)
    Table 90. Global Flu Vaccine Revenue Forecast by Application (2022-2027) & (US$ Million)
    Table 91. North America Flu Vaccine Sales by Country (2016-2021) & (M Doses)
    Table 92. North America Flu Vaccine Sales by Country (2022-2027) & (M Doses)
    Table 93. North America Flu Vaccine Revenue by Country (2016-2021) & (US$ Million)
    Table 94. North America Flu Vaccine Revenue by Country (2022-2027) & (US$ Million)
    Table 95. North America Flu Vaccine Sales by Type (2016-2021) & (M Doses)
    Table 96. North America Flu Vaccine Sales by Application (2016-2021) & (M Doses)
    Table 97. Asia-Pacific Flu Vaccine Sales by Region (2016-2021) & (M Doses)
    Table 98. Asia-Pacific Flu Vaccine Sales by Region (2022-2027) & (M Doses)
    Table 99. Asia-Pacific Flu Vaccine Revenue by Region (2016-2027) & (US$ Million)
    Table 100. Asia-Pacific Flu Vaccine Revenue by Region (2022-2027) & (US$ Million)
    Table 101. Asia-Pacific Flu Vaccine Sales by Type (2016-2021) & (M Doses)
    Table 102. Asia-Pacific Flu Vaccine Sales by Application (2016-2021) & (M Doses)
    Table 103. Europe Flu Vaccine Sales by Country (2016-2021) & (M Doses)
    Table 104. Europe Flu Vaccine Sales by Country (2022-2027) & (M Doses)
    Table 105. Europe Flu Vaccine Revenue by Country (2016-2021) & (US$ Million)
    Table 106. Europe Flu Vaccine Revenue by Country (2022-2027) & (US$ Million)
    Table 107. Europe Flu Vaccine Sales by Type (2016-2021) & (M Doses)
    Table 108. Europe Flu Vaccine Sales by Application (2016-2021) & (M Doses)
    Table 109. Latin America Flu Vaccine Sales by Country (2016-2021) & (M Doses)
    Table 110. Latin America Flu Vaccine Sales by Country (2022-2027) & (M Doses)
    Table 111. Latin America Flu Vaccine Revenue by Country (2016-2021) & (US$ Million)
    Table 112. Latin America Flu Vaccine Revenue by Country (2022-2027) & (US$ Million)
    Table 113. Latin America Flu Vaccine Sales by Type (2016-2021) & (M Doses)
    Table 114. Latin America Flu Vaccine Sales by Application (2016-2021) & (M Doses)
    Table 115. Middle East and Africa Flu Vaccine Sales by Country (2016-2021) & (M Doses)
    Table 116. Middle East and Africa Flu Vaccine Sales by Country (2022-2027) & (M Doses)
    Table 117. Middle East and Africa Flu Vaccine Revenue by Country (2016-2021) & (US$ Million)
    Table 118. Middle East and Africa Flu Vaccine Revenue by Country (2022-2027) & (US$ Million)
    Table 119. Middle East and Africa Flu Vaccine Sales by Type (2016-2021) & (M Doses)
    Table 120. Middle East and Africa Flu Vaccine Sales by Application (2016-2021) & (M Doses)
    Table 121. Flu Vaccine Key Raw Materials, Industry Status and Trend
    Table 122. Flu Vaccine Key Raw Materials and Upstream Suppliers
    Table 123. Flu Vaccine Clients Status and Trend
    Table 124. Flu Vaccine Typical Clients
    Table 125. Flu Vaccine Distributors
    Table 126. Key Drivers: Impact Analysis (2022-2027)
    Table 127. Flu Vaccine Market Drivers
    Table 128. Flu Vaccine Market Opportunities
    Table 129. Flu Vaccine Market Challenges
    Table 130. Flu Vaccine Market Restraints
    Table 131. Flu Vaccine Porter’s Five Forces Analysis
    Table 132. Research Programs/Design for This Report
    Table 133. Key Data Information from Secondary Sources
    Table 134. Key Data Information from Primary Sources
List of Figures
    Figure 1. Flu Vaccine Product Picture
    Figure 2. Global Flu Vaccine Sales Market Share by Type in 2021 & 2027
    Figure 3. Trivalent Influenza Vaccine Product Picture
    Figure 4. Quadrivalent Influenza Vaccine Product Picture
    Figure 5. Global Flu Vaccine Sales Market Share by Application in 2021 & 2027
    Figure 6. For Children (6 months to 3 years) Examples
    Figure 7. For Adults and Children over 3 years Examples
    Figure 8. Flu Vaccine Report Years Considered
    Figure 9. Global Flu Vaccine Market Size, (US$ Million), 2016 VS 2021 VS 2027
    Figure 10. Global Flu Vaccine Market Size 2016-2027 (US$ Million)
    Figure 11. Global Flu Vaccine Sales 2016-2027 (K Units)
    Figure 12. Global Flu Vaccine Market Size Market Share by Region: 2021 Versus 2027
    Figure 13. Global Flu Vaccine Sales Market Share Forecast by Region (2016-2027)
    Figure 14. Global Flu Vaccine Revenue Market Share by Region (2016-2027)
    Figure 15. Global Flu Vaccine Sales Share by Manufacturer in 2020
    Figure 16. Flu Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
    Figure 17. Global Flu Vaccine Sales Market Share Forecast by Type (2016-2027)
    Figure 18. Global Flu Vaccine Revenue Market Share Forecast by Type (2016-2027)
    Figure 19. Flu Vaccine Average Selling Price (ASP) by Type (2016-2021) & (USD/Unit)
    Figure 20. Global Flu Vaccine Sales Market Share Forecast by Application (2016-2027)
    Figure 21. Global Flu Vaccine Revenue Market Share Forecast by Application (2016-2027)
    Figure 22. Flu Vaccine Average Selling Price (ASP) by Application (2016-2021) & (USD/Unit)
    Figure 23. North America Flu Vaccine Revenue 2016-2027 (US$ Million)
    Figure 24. North America Flu Vaccine Sales Market Share by Type (2016-2021)
    Figure 25. North America Flu Vaccine Sales Market Share by Application (2016-2021)
    Figure 26. Asia-Pacific Flu Vaccine Revenue 2016-2027 (US$ Million)
    Figure 27. Asia-Pacific Flu Vaccine Sales Market Share by Region (2016-2027)
    Figure 28. Asia-Pacific Flu Vaccine Revenue Market Share by Region (2016-2027)
    Figure 29. Asia-Pacific Flu Vaccine Sales Market Share by Type (2016-2021)
    Figure 30. Asia-Pacific Flu Vaccine Sales Market Share by Application (2016-2021)
    Figure 31. Europe Flu Vaccine Revenue Growth Rate 2016-2027 (US$ Million)
    Figure 32. Europe Flu Vaccine Sales Market Share by Country (2016-2027)
    Figure 33. Europe Flu Vaccine Revenue Market Share by Country (2016-2027)
    Figure 34. Europe Flu Vaccine Sales Market Share by Type (2016-2021)
    Figure 35. Europe Flu Vaccine Sales Market Share by Application (2016-2021)
    Figure 36. Latin America Flu Vaccine Revenue Growth Rate 2016-2027 (US$ Million)
    Figure 37. Latin America Flu Vaccine Sales Market Share by Country (2016-2027)
    Figure 38. Latin America Flu Vaccine Revenue Market Share by Country (2016-2021)
    Figure 39. Latin America Flu Vaccine Sales Market Share by Type (2016-2021)
    Figure 40. Latin America Flu Vaccine Sales Market Share by Application (2016-2021)
    Figure 41. Middle East and Africa Flu Vaccine Revenue Growth Rate 2016-2027 (US$ Million)
    Figure 42. Middle East and Africa Flu Vaccine Sales Market Share by Country (2016-2027)
    Figure 43. Middle East and Africa Flu Vaccine Revenue Market Share by Country (2016-2027)
    Figure 44. Middle East and Africa Flu Vaccine Sales Market Share by Type (2016-2021)
    Figure 45. Middle East and Africa Flu Vaccine Sales Market Share by Application (2016-2021)
    Figure 46. Flu Vaccine Supply Chain (Upstream and Downstream Market)
    Figure 47. Global Production Market Share of Flu Vaccine Raw Materials by Region in 2020
    Figure 48. Flu Vaccine Distribution Channels
    Figure 49. Global Flu Vaccine Percentage 2016-2027: Indirect Sales VS Direct Sales
    Figure 50. Global Flu Vaccine Percentage 2016-2027: Online Sales VS Offline Sales
    Figure 51. Porter's Five Forces Analysis
    Figure 52. Bottom-up and Top-down Approaches for This Report
    Figure 53. Data Triangulation
    Figure 54. Key Executives Interviewed
SELECT A FORMAT
Added to Cart

Electronic (PDF)
$5900
This license allows only one user(purchaser of the report) to access the PDF.

Electronic (PDF)
$8850
This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Electronic (PDF)
$11800
This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
SecuX Technology Inc

RELATED REPORTS

China Autogenous Vaccines Market Report Forecast 2021 2027
China Autogenous Vaccines Market Report & Forecast 2021-2027

120 Pages
Type: Report
Code: QYRE-Auto-22Z1818
Sat Oct 02 00:00:00 UTC 2021

Add to Cart

Global Flu Vaccine Market Size Manufacturers Supply Chain Sales Channel and Clients 2021 2027
Global Flu Vaccine Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2021-2027

In 2020 the global Flu Vaccine market size was US 5154 million and it is expected to reach US 7293.3 million by the end of 2027 with a CAGR of 4.8 during 20212027.Global Flu Vaccine Market Size Manufacturers Supply Chain Sales Channel and Clients 20212027.

120 Pages
Type: Report
Code: QYRE-Auto-11H675
Mon Sep 27 00:00:00 UTC 2021

Add to Cart

Global Rabies Vaccine Market Size Manufacturers Supply Chain Sales Channel and Clients 2021 2027
Global Rabies Vaccine Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2021-2027

And in terms of application the largest application is Postexposure Prophylaxis followed by Preexposure Prophylaxis.Market Analysis and Insights Global Rabies Vaccine MarketIn 2020 the global Rabies Vaccine market size was US 877 million and it is expected to reach US 1178 million by the end of 2027 with a CAGR of 4.0 during 20212027.Global Rabies Vaccin.

120 Pages
Type: Report
Code: QYRE-Auto-34M23
Mon Sep 27 00:00:00 UTC 2021

Add to Cart

Global and United States Sulfachloropyridazine Sodium Market Insights Forecast to 2027
Global and United States Sulfachloropyridazine Sodium Market Insights, Forecast to 2027

120 Pages
Type: Report
Code: QYRE-Auto-28M6619
Tue Sep 21 00:00:00 UTC 2021

Add to Cart